- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
ASCO Supports Act to Reduce Co-Pays for Specialty Medications
The Patients' Access to Treatments Act of 2015 was introduced earlier this year to rein in the high cost-sharing requirements for specialty drugs.
Earlier this year, US Representatives David McKinley (R-WV) and Lois Capps (D-CA), co-sponsored the Patients' Access to Treatments Act of 2015 that is applicable to health plans that have formulariers or a tiered cost-sharing structure. The objective: reduce the increasing cost-sharing requirements for patients imposed by the preferred versus non-preferred tiering of some of the prescription medications.
The American Society of Clinical Oncology has now announced that it endorses the Act that will shield patients from mounting co-payment burdens of specialty formulations.
“The imposition of high cost-sharing requirements is increasingly becoming a barrier for cancer patients,” wrote ASCO President Julie Vose, MD, MBA, FASCO. “In some cases, cancer patients are simply unable to afford the appropriate treatment, placing them at risk of a less successful outcome, or a more debilitating treatment regimen.”
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
